The IDIBELL and Bellvitge University Hospital Psychiatry and Mental Health research group has published an article that indicates that men have a better long-term prognosis in treatment with deep brain stimulation (DBS) for Obsessive Compulsive Disorder (OCD).
Women with resistant OCD have a worse answer to deep-brain stimulation Read More »
In this event, innovative projects from the biotech and biomedical sector looking for market transfer resources will be presented.
IDIBELL celebrates a new edition of the Accelerator Meeting Point Read More »
This is a research project focused on community health that seeks to promote citizen participation in the design and co-creation of active and healthy cities
A study led by the Bellvitge Biomedical Research Institute (IBIDELL) and the University of Barcelona reveals that the TDP-43 protein is essential for forming a stable and mature blood vessel network in the central nervous system.
This study demonstrates the potential of the DISCERN application to aid medical decisions for the diagnosis of brain tumours using standard MRI.
A new tool based on Artificial Intelligence will improve brain tumour diagnosis Read More »
This 8M, IDIBELL wants to focus on cardiovascular diseases in women
8M: Every 8 minutes a woman dies of cardiovascular disease Read More »
Two IDIBELL projects, one led by Dr. Marta Crous and the other by Dr. Bárbara Rivera, have been selected to receive funding from the Association Against Cancer in Barcelona.
Worldwide, more than half a million cancers are caused by HPV. HPV is the cause of all cervical cancers and also some cancers of the vulva, penis, vagina, anus and oropharynx.
March 4, International Human Papillomavirus Awareness Day Read More »
Ander Gómez will take over from Rosa Benet as Managing Director.
Ander Gómez, new IDIBELL’s Managing Director Read More »
Maria Molina will take over from Fernando Fernández Aranda as Scientific Director.
Maria Molina, new Scientific Director of IDIBELL Read More »
